Table 1.
A Number of Successful Examples of Breast Cancer Therapy with siRNAs
siRNA Targeting | Identity of Protein | Function of Protein | Delivered by MSN | Reference |
---|---|---|---|---|
EphA2 | a transmembrane receptor tyrosine kinase | a decrease in EphA2 expression both in vitro and in vivo, correlated with reduced migration and experimental metastasis of breast cancer cells | – | 7 |
AKT1/2 | serine/threonine kinase | cancer progression and metastasis | – | 133 |
PKN3 | protein kinase N3 | knockdown of PKN3 protein not only blocks metastasis but also impairs primary breast tumor growth and angiogenesis | – | 7 |
FAK | focal adhesion kinase | cell migration and metastasis | – | 134 |
VEGF | receptor tyrosine kinase | stimulates endothelial cell proliferation and regulates vascular permeability | Yes | 79 |
Bcl2 | Bcl2 family protein | predicts response to anthracycline combination | Yes | 135 |
Mcl1 | Bcl2 family protein | autophagy inhibition | – | 136 |
Survivin | inhibitor of apoptosis (IAP) family | inhibits caspase activation, leading to negative regulation of apoptosis or programmed cell death | Yes | 101 |
P-gp | ATP-dependent drug efflux pump | decreases chemotherapy drug concentrations and chemoresistance development | Yes | 12 |
c-myc | oncogene | resistance development | – | 7 |
BRCA | tumor suppressor gene | DNA repair | – | 137, 138 |
EGFR | receptor tyrosine kinase | cell proliferation and differentiation | – | 139 |
c-KIT | receptor tyrosine kinase | cell survival, proliferation, and differentiation | – | 140 |